Ebola haemorrhagic fever

被引:980
作者
Feldmann, Heinz [1 ,2 ]
Geisbert, Thomas W. [3 ,4 ]
机构
[1] NIAID, Virol Lab, Div Intramural Res, NIH,Rocky Mt Labs, Hamilton, MT 59840 USA
[2] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada
[3] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX USA
[4] Galveston Natl Lab, Galveston, TX USA
基金
加拿大健康研究院; 美国国家卫生研究院;
关键词
PROTECTS NONHUMAN-PRIMATES; VIRUS-INFECTION; GUINEA-PIGS; POSTEXPOSURE PROTECTION; DENDRITIC CELLS; MARBURG-VIRUS; PERSISTENT INFECTION; IN-VITRO; VACCINE; CONGO;
D O I
10.1016/S0140-6736(10)60667-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Ebola viruses are the causative agents of a severe form of viral haemorrhagic fever in man, designated Ebola haemorrhagic fever, and are endemic in regions of central Africa. The exception is the species Reston Ebola virus, which has not been associated with human disease and is found in the Philippines. Ebola virus constitutes an important local public health threat in Africa, with a worldwide effect through imported infections and through the fear of misuse for biological terrorism. Ebola virus is thought to also have a detrimental effect on the great ape population in Africa. Case-fatality rates of the African species in man are as high as 90%, with no prophylaxis or treatment available. Ebola virus infections are characterised by immune suppression and a systemic inflammatory response that causes impairment of the vascular, coagulation, and immune systems, leading to multiorgan failure and shock, and thus, in some ways, resembling septic shock.
引用
收藏
页码:849 / 862
页数:14
相关论文
共 139 条
[1]  
[Anonymous], INFECT CONTROL VIRAL
[2]  
Arata A., 1978, EBOLA VIRUS HAEMORRH, P191
[3]   Apoptosis in fatal Ebola infection. Does the virus toll the bell for immune system? [J].
Baize, S ;
Leroy, EM ;
Mavoungou, E ;
Fisher-Hoch, SP .
APOPTOSIS, 2000, 5 (01) :5-7
[4]   Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients [J].
Baize, S ;
Leroy, EM ;
Georges-Courbot, MC ;
Capron, M ;
Lansoud-Soukate, J ;
Debré, P ;
Fisher-Hoch, SP ;
McCormick, JB ;
McCormick, JB ;
Georges, AJ .
NATURE MEDICINE, 1999, 5 (04) :423-426
[5]   Inflammatory responses in Ebola virus-infected patients [J].
Baize, S ;
Leroy, EM ;
Georges, AJ ;
Georges-Courbot, MC ;
Capron, M ;
Bedjabaga, I ;
Lansoud-Soukate, J ;
Mavoungou, E .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2002, 128 (01) :163-168
[6]   Discovery of Swine as a Host for the Reston ebolavirus [J].
Barrette, Roger W. ;
Metwally, Samia A. ;
Rowland, Jessica M. ;
Xu, Lizhe ;
Zaki, Sherif R. ;
Nichol, Stuart T. ;
Rollin, Pierre E. ;
Towner, Jonathan S. ;
Shieh, Wun-Ju ;
Batten, Brigid ;
Sealy, Tara K. ;
Carrillo, Consuelo ;
Moran, Karen E. ;
Bracht, Alexa J. ;
Mayr, Gregory A. ;
Sirios-Cruz, Magdalena ;
Catbagan, Davinio P. ;
Lautner, Elizabeth A. ;
Ksiazek, Thomas G. ;
White, William R. ;
McIntosh, Michael T. .
SCIENCE, 2009, 325 (5937) :204-206
[7]   ULTRASTRUCTURAL PATHOLOGY OF EXPERIMENTAL EBOLA HEMORRHAGIC-FEVER VIRUS-INFECTION [J].
BASKERVILLE, A ;
FISHERHOCH, SP ;
NEILD, GH ;
DOWSETT, AB .
JOURNAL OF PATHOLOGY, 1985, 147 (03) :199-209
[8]   The Ebola virus VP35 protein functions as a type IIFN antagonist [J].
Basler, CF ;
Wang, XY ;
Mühlberger, E ;
Volchkov, V ;
Paragas, J ;
Klenk, HD ;
Garcia-Sastre, A ;
Palese, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (22) :12289-12294
[9]  
Basler CF, 2004, EBOLA AND MARBURG VIRUSES: MOLECULAR AND CELLULAR BIOLOGY, P305
[10]   The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3 [J].
Basler, CF ;
Mikulasova, A ;
Martinez-Sobrido, L ;
Paragas, J ;
Mühlberger, E ;
Bray, M ;
Klenk, HD ;
Palese, P ;
García-Sastre, A .
JOURNAL OF VIROLOGY, 2003, 77 (14) :7945-7956